RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Finding disease markers in tiny particles from body fluids

Researchers are analysing proteins and genetic material in spinal fluid and urine to investigate neurological diseases.

Testing a treatment or activity · Study reference: JPRN-UMIN000015133

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Results reported

Start (reported date)
2014-10-01
Study finished (reported date)
2019-09-30

Planned dates can move. A study finishing does not tell us when a paper will be published.

Read the results reported in the registry

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age range not listed · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: male and female

Inclusion criteria: Subjects are the patients having neurodegenerative diseases (such as amyotrophic lateral sclerosis, Parkinson disease, multiple system atrophy, progressive supranuclear palsy or corticobasal syndrome) and other diseases, who are required to have examination of cereblospinal fluid and urine. 20 patients of each neurodegenerative disease and 30 patients with other disease will be attended. Exclusion criteria: The participants are not limited by the age or gender.
Full study name & original research details

Official study title

Development of novel biomarkers of neurodegenerative diseases-comprehensive analysis of the proteins and the RNAs in exosomes extracted from cerebrospinal fluid and urine - Development of novel biomarkers in exosomes extracted from cerebrospinal fluid and urine

Short title used by the registry

Development of novel biomarkers of neurodegenerative diseases-comprehensive analysis of the proteins and the RNAs in exosomes extracted from cerebrospinal fluid and urine

Original description

Intervention: Examination of cerebrospinal fluid and urine will be conducted, but no interventions are planned. Primary outcome: Identification of novel biomarkers

Conditions reported: Neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
Examination of cerebrospinal fluid and urine will be conducted, but no interventions are planned.
Phases
Not applicable
Sponsor
Department of Neurology and Stroke Medicine, Yokohama City University
Start date reported by registry
2014-10-01 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Hiroshi Doi · 045-787-2511 · doi@rkd.d-bs.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Japan

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.